Trial Profile
A One-Arm Exploratory Clinical Trial of Apatinib Plus Gemcitabine in Patients With Advanced Metastatic Pancreatic Cancer
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 11 Jul 2018
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary) ; Gemcitabine
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Acronyms OECTAPGAMPC
- 17 Aug 2016 New trial record